Axa SA (CS) Given Buy Rating at Deutsche Bank AG
A number of other equities analysts have also recently weighed in on CS. JPMorgan Chase & Co. set a €26.00 ($28.89) price target on shares of Axa SA and gave the stock a buy rating in a research note on Tuesday, June 14th. Independent Research GmbH set a €23.00 ($25.56) price target on shares of Axa SA and gave the stock a neutral rating in a research note on Wednesday, June 22nd. BNP Paribas set a €25.00 ($27.78) price objective on shares of Axa SA and gave the stock a buy rating in a research report on Monday, June 27th. Bank of America Corp. set a €20.00 ($22.22) price objective on shares of Axa SA and gave the stock a neutral rating in a research report on Monday, June 27th. Finally, Barclays PLC set a €20.80 ($23.11) price objective on shares of Axa SA and gave the stock a buy rating in a research report on Wednesday, June 29th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and fifteen have given a buy rating to the company’s stock. The company currently has an average rating of Buy and an average target price of €23.46 ($26.07).
Axa SA (EPA:CS) traded up 1.69% during midday trading on Friday, reaching €20.50. 5,155,330 shares of the company traded hands. The firm has a market capitalization of €49.53 billion and a PE ratio of 9.08. Axa SA has a 12 month low of €16.11 and a 12 month high of €26.02. The company’s 50-day moving average price is €18.85 and its 200 day moving average price is €19.71.
About Axa SA
AXA SA (AXA) is a holding company engaged in the business of financial protection. The Company operates in five segments: Life & Savings, Property & Casualty, International Insurance, Asset Management and Banking. The Company offers a range of life and savings products, including individual and group savings retirement products, life and health products.
Receive News & Stock Ratings for Axa SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axa SA and related stocks with our FREE daily email newsletter.